1. Home
  2. QNRX vs KITT Comparison

QNRX vs KITT Comparison

Compare QNRX & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • KITT
  • Stock Information
  • Founded
  • QNRX 2018
  • KITT 2014
  • Country
  • QNRX United States
  • KITT United States
  • Employees
  • QNRX N/A
  • KITT N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • KITT Industrial Machinery/Components
  • Sector
  • QNRX Health Care
  • KITT Industrials
  • Exchange
  • QNRX Nasdaq
  • KITT Nasdaq
  • Market Cap
  • QNRX 5.3M
  • KITT 5.8M
  • IPO Year
  • QNRX N/A
  • KITT N/A
  • Fundamental
  • Price
  • QNRX $0.57
  • KITT $2.26
  • Analyst Decision
  • QNRX Strong Buy
  • KITT
  • Analyst Count
  • QNRX 1
  • KITT 0
  • Target Price
  • QNRX $4.00
  • KITT N/A
  • AVG Volume (30 Days)
  • QNRX 1.4M
  • KITT 17.0M
  • Earning Date
  • QNRX 03-12-2025
  • KITT 11-12-2024
  • Dividend Yield
  • QNRX N/A
  • KITT N/A
  • EPS Growth
  • QNRX N/A
  • KITT N/A
  • EPS
  • QNRX N/A
  • KITT N/A
  • Revenue
  • QNRX N/A
  • KITT $2,399,852.00
  • Revenue This Year
  • QNRX N/A
  • KITT $980.78
  • Revenue Next Year
  • QNRX N/A
  • KITT N/A
  • P/E Ratio
  • QNRX N/A
  • KITT N/A
  • Revenue Growth
  • QNRX N/A
  • KITT N/A
  • 52 Week Low
  • QNRX $0.43
  • KITT $0.82
  • 52 Week High
  • QNRX $6.18
  • KITT $17.14
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 43.80
  • KITT 51.00
  • Support Level
  • QNRX $0.56
  • KITT $1.91
  • Resistance Level
  • QNRX $0.63
  • KITT $3.44
  • Average True Range (ATR)
  • QNRX 0.07
  • KITT 1.02
  • MACD
  • QNRX -0.00
  • KITT -0.07
  • Stochastic Oscillator
  • QNRX 11.56
  • KITT 16.74

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About KITT Nauticus Robotics Inc.

Nauticus Robotics Inc develops autonomous robots for the ocean industries. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus' services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.

Share on Social Networks: